title: Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Campisi
authors.forename: Stefano
authors.initials: S
authors.lastname: Fedele
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Colella
authors.forename: Antonio
authors.initials: A
authors.lastname: Lo Casto
authors.forename: Vittorio
authors.initials: V
authors.lastname: Fusco
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects; D002170:Canada / Q000453:epidemiology; D015984:Causality; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D008991:Monitoring, Physiologic / Q000592:standards; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D010024:Osteoporosis / Q000188:drug therapy; D010510:Periodontal Diseases / Q000150:complications / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011313:Preventive Dentistry / Q000592:standards; D040242:Risk Reduction Behavior
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates